French nutrition specialist Eric Favre Laboratoire is expanding its pediatric supplement portfolio with Special GROWTH AlgaOmega, a microalgae-derived omega-3 formulation designed for children aged three and over. The product enters a pediatric omega-3 market that has seen sustained pressure from parents seeking fish-free and sustainably sourced alternatives to conventional fish oil capsules.

Special GROWTH AlgaOmega delivers both DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) from microalgae — the same marine organisms that accumulate these long-chain polyunsaturated fatty acids before they enter the fish food chain. By sourcing at the algal level, the finished formulation bypasses the fishy taste and odor that frequently undermine compliance in children's supplements, while also eliminating exposure to ocean-sourced contaminants commonly associated with fish-oil concentrates. The formula is rounded out with vitamins A, D3, E, and K2, a combination frequently positioned around bone development, immune support, and antioxidant protection in the pediatric segment.

Why Algae, Why Now

Microalgae-sourced omega-3 has moved from a niche vegan positioning to a broadly appealing clean-label ingredient story. Major ingredient suppliers have invested heavily in fermentation and cultivation scale-up over the past five years, bringing cost parity with fish oil closer than at any previous point. For pediatric applications specifically, the algal route offers a structure-function claim narrative around both cognitive development (DHA is a recognized contributor to normal brain function under EU nutrition regulations) and cardiovascular health, without the allergen and sustainability concerns that increasingly influence parental purchase decisions in the European market.

Eric Favre's Special Kid range is an established vehicle in French pharmacy and parapharmacy channels, giving AlgaOmega a credentialed retail pathway that many ingredient-led launches lack. The addition of K2 — often paired with D3 in bone-health formulations to support calcium utilization — signals a premium, multi-benefit positioning rather than a commodity omega-3 play. Operators and contract manufacturers watching the pediatric supplement space will note the multi-nutrient stack as a point of differentiation in a category where single-ingredient DHA gummies remain the dominant format.

Market & Operator Context

The global omega-3 ingredients market continues to grow, with algal omega-3 among its fastest-expanding sub-segments as sustainability certifications and vegan demographics broaden the addressable consumer base beyond plant-based households. Pediatric nutrition remains one of the highest-trust, highest-margin segments in the supplement aisle, and fish-free DHA positioning resonates with the same clean-label trends driving reformulation activity across functional foods and beverages. Brands developing children's products for EU distribution must also navigate EFSA's substantiated health claim framework, where DHA's role in normal visual and brain development in infants and young children carries approved status — a regulatory tailwind for algae-sourced launches like this one.

For specialty retailers and pharmacy buyers evaluating the children's supplement category, AlgaOmega's fish-oil-free credential addresses a growing list-request from consumers navigating fish allergies, sustainability preferences, and palatability challenges simultaneously.

Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.